Timken India Limited
Quality (64/100) does the heavy lifting; valuation (2/100) is the drag.
ExpensiveOvervaluedTimken India Limited earns a Sell from StocksWizard, with a blended score of 31/100. At ₹3,096.6 it trades above our blended DCF and relative-multiples fair value of ₹1,548.3, about 50% downside to that estimate — we read it as overvalued by 50%. On 68.4x trailing earnings it sits pricier than the Industrials median of about 29.0x. The price is about 18% below its 52-week high of ₹3,767.1 and 9% above the low of ₹2,835.7. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9. The average analyst target of ₹3,987.71 implies about 29% upside across 7 analysts. It clears 6 of 13 investability checks, with durability 64, valuation 4 and momentum 22 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹1,238.64.
Analyst views
1-year price
EOD · 2026-07-2952-week range
-17.80% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell31Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 14.4%
- Pass: Low debt (D/E < 0.5): 0.01x
- Pass: Positive free cash flow
- Pass: Revenue growth > 10%: 16%
- Fail: Earnings growing: -15%
- Pass: Net margin ≥ 10%: 11.9%
- Pass: Current ratio > 1.5: 2.97
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 23.8
- Fail: Piotroski ≥ 7: 4/9
Quarterly results
Annual financials
Shareholding
- Promoter52.4%
- Institutions33.1%
- Public & other14.5%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 23.8.
Opportunities
- Revenue growing (16% YoY).
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
Threats
- Earnings contracting year on year.
- Rich valuation versus sector peers.
- Trades ~50% above our estimated fair value.
About Timken India Limited
Timken India Limited manufactures and distributes tapered roller bearings, ball bearings, cylindrical roller bearings, spherical roller bearings, needle and thrust bearings, housed units, wheel hub units, and driveline support bearings, along with related mechanical power transmission products, serving markets in India, the United States, and internationally.
Timken India Limited — frequently asked questions
Is Timken India Limited a buy, hold or sell?
StocksWizard currently rates Timken India Limited (TIMKEN) a Sell, based on a blended score of 31/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Timken India Limited's fair value?
Our blended DCF and relative-valuation model estimates Timken India Limited's fair value at about ₹1,548.3, versus a current price of ₹3,096.6 — roughly 50% downside. On that basis the stock looks overvalued by 50%.
Is Timken India Limited financially healthy?
Timken India Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Timken India Limited's share price performed?
Timken India Limited is down 10% over three months, and last traded at ₹3,096.6. Past performance doesn't predict future returns.
More in Industrials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.